2BBBullish & Bearish
DexCom, Inc. (DXCM) trades on NASDAQ. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 64 out of 100.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
DexCom, Inc.’s current 2BB score is 64 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 62 | High |
| Momentum | 50 | Stable |
| Financial strength | 91 | Very Strong |
| Quality | 100 | Very Strong |
| Risk | 34 | Low |
| CEO | Kevin R. Sayer |
| Headquarters | San Diego, California, United States |
| Founded | 1999 |
| Employees | 11K |
| P/E ratio | 35.43 |
| 52-week range | $54.11 – $92.59 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | 0.7483 | — | $1.43B |
| 2026-10-28 | — | 0.6846 | — | $1.36B |
| 2026-07-30 | — | 0.622 | — | $1.32B |
| 2026-04-30 | 0.56 | 0.4785 | $1.19B | $1.20B |